Despite this, no significant association between the reduced TSPYL2 expression and survival could be observed in sex-specific tumors, while a correlation was found in lung adenocarcinoma, osteosarcoma and pancreatic cancer. Here, TSPYL2 is linked to lung adenocarcinoma.